Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 270

The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.

Frontal, midbrain and striatal dopaminergic function in early and advanced Parkinson's disease A 3D [18F]dopa-PET study

Open access
Rakshi, J. S., Uema, T., Ito, K., Bailey, D. L., Morrish, P. K., Ashburner, J., Dagher, A., Jenkins, I. H., Friston, K. J., Brooks, D. J. · 1999 · Brain

Abstract

We have studied focal changes in dopaminergic function throughout the brain volume in early and advanced Parkinson's disease by applying statistical parametric mapping (SPM) to 3D [(18)F]dopa-PET. Data from seven early hemi-Parkinson's disease and seven advanced bilateral Parkinson's disease patients were compared with that from 12 normal controls. Parametric images of [(18)F]dopa influx rate constant (K(i)(o)) were generated for each subject from dynamic 3D [(18)F]dopa datasets and transformed into standard stereotactic space. Significant changes in mean voxel [(18)F]dopa K(i)(o) values between the normal control group and each Parkinson's disease group were localized with SPM. Conventional region of interest analysis was also applied to comparable regions on the untransformed image datasets. In early left hemi-Parkinson's disease, significant extrastriatal increases in [(18)F]dopa K(i)(o) were observed in the left anterior cingulate gyrus and the dorsal midbrain region (P < 0.05, corrected) along with decreases in striatal [(18)F]dopa K(i)(o). In advanced Parkinson's disease, significant extrastriatal decreases in [(18)F]dopa K(i)(o) were observed in the ventral and dorsal midbrain regions (P < 0.05, corrected). No significant changes in [(18)F]dopa K(i)(o) were observed in the anterior cingulate region. In a direct comparison between the early and late Parkinson's disease groups, we observed relative [(18)F]dopa K(i)(o) reductions in ventral and dorsal midbrain, and dorsal pontine regions along with striatal [(18)F]dopa K(i)(o) reductions. Similiar results were found with a region of interest approach, on non-transformed data, except for the focal midbrain [(18)F]dopa K(i)(o) increase seen in early Parkinson's disease. In conclusion, using SPM with [(18)F]dopa-PET, we have objectively localized changes in extrastriatal, pre-synaptic dopaminergic function in Parkinson's disease. The significance of the increased dopaminergic activity of anterior cingulate in early Parkinson's disease remains unclear, but may be compensatory. The [(18)F]dopa signal in dorsal midbrain and pontine regions suggests that [(18)F]dopa is taken up by serotonergic and noradrenergic neurons which also degenerate in advanced Parkinson's disease. This suggests, therefore, that Parkinson's disease is a monoaminergic neurodegenerative disorder.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/brain/122.9.1637

Cites

55 of 55 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 55 references

Research works printed but not linked: 10

  1. Badawi RD. 3D-Mode acquisition in clinical PET [editorial]. Nuc Med Commun1997; 18: 801–4. · doi:10.1097/00006231-199704000-00079
  2. Bailey DL. 3D acquisition and reconstruction in positron emission tomography. [Review]. Ann Nucl Med1992; 6: 123–30. · doi:10.1007/bf03178303
  3. Cherry SR, Meikle SR, Hoffman EJ. Correction and characterization of scattered events in three-dimensional PET using scanners with retractable septa. J Nucl Med1993; 34: 671–8.
  4. Cumming P, Gjedde A, Reith J. Controversies arising from recent FDOPA articles [letter; comment] [see comments]. J Nucl Med1997; 38: 1267–71. Comment on: J Nucl Med 1996; 37: 209–22, Comment on: J Nucl Med 1996; 37: 432–7, Comment in: J Nucl Med 1997; 38: 1267–71.
  5. Dhawan V, Ishikawa T, Patlak C, Chaly T, Robeson W, Belakhet A, et al. Combined FDOPA and 3OMFD PET studies in Parkinson's disease [see comments]. J Nucl Med1996; 37: 209–16. Comment in: J Nucl Med 1997; 38: 1267–71.
  6. Ichise M, Ballinger JR. Physiologic modelling of PET data: quantitative conflict and challenge [editorial; comment]. J Nucl Med1997; 38: 1266–72. Comment on: J Nucl Med 1997; 38: 1267–2.
  7. Melamed E, Hefti F, Wurtman RJ. Compensatory mechanisms in the nigrostriatal dopaminergic system in parkinson's disease: studies in an animal model. Is J Med Sci1982; 18: 159–62.
  8. Richardson MP, Koepp MJ, Brooks DJ, Fish DR, Duncan JS. Benzodiazepine receptors in focal epilepsy with cortical dysgenesis: an 11C-flumazenil PET study. Ann Neurol1996; 40: 188–98. · doi:10.1002/ana.410400210
  9. Tison F, Normand E, Jaber M, Aubert I, Bloch B. Aromatic L-amino-acid decarboxylase (DOPA decarboxylase) gene expression in dopaminergic and serotoninergic cells of the rat brainstem. Neurosci Lett1991; 127: 203–6. · doi:10.1016/0304-3940(91)90794-t
  10. Trebossen R, Bendriem B, Fontaine A, Frouin V, Remy P. Quantification of the [18F]fluorodopa uptake in the human striata in 3D PET with the ETM scatter correction. In: Myers R, Cunningham V, Bailey DL, Jones T, editors. Quantification of brain function using PET. San Diego: Academic Press; 1996. p. 88–92. · doi:10.1016/b978-012389760-2/50020-7

Cited by

See all 270

Metadata

Authors
Rakshi, J. S., Uema, T., Ito, K., Bailey, D. L., Morrish, P. K., Ashburner, J., Dagher, A., Jenkins, I. H., Friston, K. J., & Brooks, D. J.
Venue
Brain
Published
1999-09
Volume
122
Issue
9
Pages
1637-1650
ISSN
  • 0006-8950 (ISSN-L)
  • 1460-2156
OpenAlex
W2154272661
Cited by
270
References
55
FWCI
6.37
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Frontal, midbrain and striatal dopaminergic function in early and advanced Parkinson's disease A 3D [18F]dopa-PET study. https://app.cochat.ai/papers/10.1093/brain/122.9.1637
The paper
Rakshi, J. S., Uema, T., Ito, K., Bailey, D. L., Morrish, P. K., Ashburner, J., Dagher, A., Jenkins, I. H., Friston, K. J., & Brooks, D. J. (1999). Frontal, midbrain and striatal dopaminergic function in early and advanced Parkinson's disease A 3D [18F]dopa-PET study. Brain. https://doi.org/10.1093/brain/122.9.1637

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.